QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
Tesaro, Inc.
Trishula Therapeutics, Inc.
IGM Biosciences, Inc.
Karyopharm Therapeutics Inc
Eli Lilly and Company
Biosplice Therapeutics, Inc.
Cantargia AB
Eli Lilly and Company